Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
144.00
Ask:
145.00
Spread: 1.00 (0.694%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement-COVID-19 & Preliminary Statement

23 Mar 2020 17:47

RNS Number : 2844H
Xaar PLC
23 March 2020
 

Xaar plc

 

Trading update and revised date for full year results 

 

Xaar plc ("Xaar" or the "Group"), the leading inkjet printing technology Group, announces a confirmation of previous guidance and a revised date for the presentation of full year results.

 

Full year results

 

Preliminary financial statements for the 12 months ended 31 December 2019 were scheduled to be released 24 March 2020.

 

The FCA has strongly requested all listed companies observe a moratorium on the publication of preliminary financial statements for at least two weeks.

 

In compliance with this request, Xaar will not be releasing preliminary financial statements, but will publish full audited financial statements within four months of the financial year end, subject to any further guidance from the FCA.

 

Trading update

 

Xaar continues to make good progress with its strategy and re-iterates the preliminary guidance for 2019:

 

The Group expects to report revenues for its continuing operations of £49.4 million for the year ended 31 December 2019.

 

Group cash balances (including cash held for investment in Xaar 3D) were £25.3 million at 31 December 2019.

 

COVID19 - Update

 

The health, safety and security of our employees is our upmost priority and appropriate actions have been taken to our operational procedures to mitigate risk.

 

The Group's trading performance in 2020 to date has been in line with expectations. No orders have been cancelled, however we are mindful of the rapidly changing environment in which the business is operating.

 

While the full implications of COVID-19 on the financial performance for the current financial year are difficult to determine at this stage, the Board remains confident in the long-term prospects of the Group.

 

 

Enquiries:

Xaar plc

+44 (0)1223 423 663 

John Mills, Chief Executive Officer

Ian Tichias, Chief Finance Officer

 

 

Tulchan Communications

+44 (0)20 7353 4200

James Macey White

Giles Kernick

Hollie Ralston

 

About XaarXaar is a world leader in the development of digital inkjet technology. Our technology drives the conversion of analogue printing and manufacturing methods to digital inkjet which is more efficient, more economical and more productive than the traditional methods which have been in use for years. We design and manufacture printheads as well as systems for product decoration and industrial 3D Printing which use our inkjet technology. We are the only truly independent inkjet technology company with over 25 years of know how. We offer unrivalled inkjet expertise including technology and printhead design and development and manufacture highly customised product decoration systems and industrial 3D Printing for volume manufacturing. Our unique technologies and products are the leading enabler for innovation and for driving supply chain efficiencies for many industries. Information about Xaar is at www.xaar.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPPUQCWUPUGMW
Date   Source Headline
27th Mar 20077:00 amRNSDirector/PDMR Shareholding
21st Mar 20077:00 amRNSHolding(s) in Company
20th Mar 20071:38 pmRNSHolding(s) in Company
19th Mar 20074:02 pmRNSHolding(s) in Company
15th Mar 200711:29 amRNSDividend Record Date Amendmnt
15th Mar 20077:01 amRNSFinal Results
6th Mar 20076:30 pmRNSHolding(s) in Company
15th Feb 20077:01 amRNSNotice of Final Results
14th Feb 20077:01 amRNSOffer Talks Terminated
12th Feb 20076:22 pmRNSHolding(s) in Company
9th Feb 200712:02 pmRNSEPT Disclosure
9th Feb 200710:14 amRNSRule 8.3- Xaar PLC
8th Feb 200711:53 amRNSRule 8.3- Xaar PLC
7th Feb 200711:20 amRNSEPT Disclosure
5th Feb 200710:56 amRNSEPT Disclosure
2nd Feb 200712:12 pmRNSEPT Disclosure
2nd Feb 200710:35 amRNSRule 8.3- Xaar PLC
31st Jan 200712:38 pmRNSRule 8.3- Xaar PLC
31st Jan 200712:02 pmRNSRule 8.3- Xaar PLC
30th Jan 20071:07 pmPRNRule 8.3 - XAAR PLC
30th Jan 200710:48 amRNSRule 8.3- Xaar PLC
29th Jan 20079:46 amRNSRule 8.3- Xaar PLC
25th Jan 200710:32 amRNSEPT Disclosure
25th Jan 200710:21 amRNSRule 8.3- Xaar PLC
24th Jan 200710:06 amRNSRule 8.3- Xaar PLC
23rd Jan 20079:19 amRNSRule 8.3- Xaar PLC
22nd Jan 200711:32 amRNSRule 8.3- Xaar PLC
19th Jan 20079:45 amRNSRule 8.3- Xaar
17th Jan 200711:54 amRNSEPT Disclosure
16th Jan 200711:48 amRNSEPT Disclosure
16th Jan 20079:52 amRNSRule 8.3- Xaar PLC
15th Jan 200711:01 amRNSRule 8.3- Xaar PLC
12th Jan 200710:30 amRNSEPT Disclosure
29th Dec 20069:20 amRNSAdditional Listing
28th Dec 200611:46 amRNSEPT Disclosure
28th Dec 20068:50 amRNSAdditional Listing
27th Dec 20069:03 amRNSAdditional Listing
22nd Dec 20068:32 amRNSAdditional Listing
21st Dec 200612:28 pmRNSEPT Disclosure
21st Dec 200610:30 amRNSAdditional Listing
21st Dec 200610:29 amRNSAdditional Listing
20th Dec 20064:22 pmRNSHolding(s) in Company
19th Dec 200612:21 pmRNSTotal Voting Rights
19th Dec 200612:02 pmRNSEPT Disclosure
18th Dec 20061:34 pmRNSEPT Disclosure
18th Dec 20061:07 pmRNSRule 8.3- Xaar PLC
15th Dec 200612:45 pmRNSEPT Disclosure
12th Dec 20061:02 pmRNSEPT Disclosure
11th Dec 200611:52 amPRNRule 8.3
8th Dec 200612:29 pmRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.